Abstract:Severe maternal and newborn morbidity and mortality associated with pre-eclampsia, which are caused partly by premature delivery, affect a factual proportion of pregnancies. Despite its prevalence, the underlying causes of pre-eclampsia remain elusive, with emerging evidence implicating the aryl hydrocarbon receptor (AhR) in its pathogenesis. This study sought to elucidate the involvement of the AhR and its associated pathway in pre-eclampsia by comparing placental components of the AhR pathway in pregnant individuals with and without pre-eclampsia. This case-control investigation was conducted at the University Hospital of Udine from May 2021 to February 2023. The AhR was assessed using immunohistochemistry and immunofluorescence, and its mRNA was evaluated using a Real-Time Quantitative Reverse Transcription PCR. Levels of mRNA expression were also estimated for other components of the AhR pathway (CYP1B1, IDO1, ARNT, TIPARP, S100A4, and AHRR). Our findings show decreased levels of expression of AhR, IDO1, ARNT, TiPARP, and S100A4 in the placental tissues of individuals with pre-eclampsia compared to controls (p < 0.05). The AhR exhibited a distinct localization within the syncytiotrophoblast (nuclei and cytoplasm) and CD45-positive cells (nuclei and cytoplasm). Furthermore, a significant positive correlation between the AhR and S100A4 (rho = 0.81) was observed in normal placentas, while CYP1B1 displayed a significant negative correlation with the AhR (rho = -0.72), within addition to its negative correlation with TiPARP (rho = -0.83). This study illuminates pre-eclampsia's molecular aberrations, suggesting new diagnostic, therapeutic, and mechanistic approaches. This study emphasizes the need for more research to validate and broaden these findings to improve the management of this complex pregnancy condition.

Expression and significance of liver-X-receptor-alpha in placenta of women with pregnancy associated hypertension

Serum and Placental Interleukin-18 Are Elevated in Preeclampsia

Progress in Soluble Vascular Endothelial Growth Factor Receptor-1 and Preeclampsia

Association of a Reduction of G-protein Coupled Receptor 30 Expression and the Pathogenesis of Preeclampsia

[Expression of Fas and FasL in Serum and Placenta of Preeclamptic Pregnancy and Its Significance].

Study on the expression of LCHAD mRNA in placenta of normal pregnancy and sever preeclampsia

Changes of Endoglin in Maternal Serum and Placenta in Hypertensive Disorder Complicating Pregnancy

Alteration in placental expression of bile acids transporters OATP1A2, OATP1B1, OATP1B3 in intrahepatic cholestasis of pregnancy

Declined placental PLAC1 expression is involved in preeclampsia.

Activation of LXRα attenuates 2-Ethylhexyl diphenyl phosphate (EHDPP) induced placental dysfunction

[Relationship Between Serum and Placental Interleukin-18 Levels and Preeclampsia].

Alterations Of Serum Resistin In Normal Pregnancy And Pre-Eclampsia

Expression of Relaxin Receptor in Placental Tissues of Normal Pregnancy and Pre-Eclampsia

Placental Proteome Alterations in Women with Intrahepatic Cholestasis of Pregnancy.

Placental Imbalance of Th1‐ and Th2‐type Cytokines in Preeclampsia

Interaction Between Peroxisome Proliferator-Activated Receptor-Gamma and Tumor Necrosis Factor-Alpha in Pathogenesis of Severe Preeclampsia

Examining the Aryl Hydrocarbon Receptor Network in the Placental Tissues of Pregnancies Complicated by Pre-Eclampsia: An Explorative Case-Control Analysis

Alterations in Serum Adipocyte Fatty Acid Binding Protein and Retinol Binding Protein-4 in Normal Pregnancy and Preeclampsia.

Serum Adiponectin, Leptin and Soluble Leptin Receptor in Pre-Eclampsia.

Expression of Placental Vascular Growth Factor in Pregnancy-Induced Hypertension

Elevated Serum Levels of Interleukin-15 and Interleukin-16 in Preeclampsia.